Bringing the fundamentals into focus…
Back to CONMED Corporation
How CONMED Corporation stacks up
CNMD · against 455 other Healthcare companies of similar size
Valuation
68/ 100
Above the middle of the pack.
Ranked #169 of 456 · scores higher than 62% of peers
Bars: peers in each 10-point band of the valuation score45 peers with a valuation score of 60–69, including CNMD · Click a bar to see the companies
Why valuation scores 68?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its free cash flow yield, EBITDA yield and earnings yield, which are stronger than most Healthcare peers.
- higher earnings for the price paid: stronger than 71% of peers. Earnings yield: 4.0% vs peer median 1.5%
- more operating profit (EBITDA) for the company's total value: stronger than 81% of peers. EBITDA yield: 7.3% vs peer median 4.0%
- more free cash flow for the price paid: stronger than 92% of peers. Free cash flow yield: 9.5% vs peer median 0.0%
Metric by metric
Position: dot = CNMD, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | CNMD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 445 reported | 3.9% | 1.5% | 66% | 30% | |
| EBITDA yieldHigher is better · 459 reported | 10.3% | 4.5% | 79% | 50% | |
| Free cash flow yieldHigher is better · 208 reported | 9.5% | -0.7% | 89% | 20% | |
| Book yieldHigher is better · 449 reported | 73.5% | 40.4% | 80% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around CNMDScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score